Automated Cell Culture Market size is estimated to reach USD 39.43 Billion by the end of 2036, growing at a CAGR of 8.70% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of automated cell culture was USD 13.47 Billion. The market for automated cell culture is expanding due in large part to an increase in clinical trials and investments in customized medications in developing nations like Australia, China, the US, India, and others. Automated cell culture systems are mostly used in labs that perform tasks like drug discovery, protein expression, cell signaling, and other related tasks. These solutions assist save time and prevent mistakes made by technicians. It is undoubtedly a very useful tool for researching diseases in humans. Approximately USD 97 million was the suggested investment value for the Indian pharmaceutical and medicine industries in the fiscal year 2022.
In addition to these, numerous elements have shown themselves to be accountable for the automated cell culture market expansion for automated cell culture. Among the few are stem cell development and research, drug discovery, and greater investments in the creation of new products. Gene therapy and vaccine production have grown, among other things.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
8.70% |
|
Base Year Market Size (2023) |
USD 13.47 Billion |
|
Forecast Year Market Size (2036) |
USD 39.43 Billion |
|
Regional Scope |
|
Product Type (Consumables, Equipment)
The equipment segment in the automated cell culture market is the largest and is expected to reach USD 24.06 billion by 2036, rising at a substantial CAGR of 8.49% between 2023 and 2036. In 2023, the segment was worth USD 8.43 billion. Equipment for automated cell culture is designed to streamline and expedite any cell culture process. Because automated cell culture instruments perform the necessary duties to establish and maintain a cell culture mechanically, they are used in laboratories. Automated cell culture equipment can perform several activities, such as plating cultures, dilution of samples, continuous spinning of cultures in liquid culture, and well-depositing of cultures. Because automated cell culture systems can generate the best cell lines over the whole range of seeding, feeding, massaging, and cell multiplication, their popularity has grown. They help achieve high standards and criteria while reducing human error. The need for automated cell culture equipment is growing as high-throughput cell lines are used in more drug discovery studies.
End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes)
Automated cell culture market from the pharmaceutical & biotechnology companies segment was assessed at USD 5.84 billion in 2023 and is expected to have a value of USD 17.66 billion by 2036, rising at a substantial CAGR of 8.98% during the projected time frame. Over the course of the projected period, the pharmaceutical and biotechnology businesses segment is anticipated to keep the majority share. The growing prevalence of chronic illnesses and the growth of research and development in the biotechnology and pharmaceutical industries are factors contributing to this sector's sizeable market share. Furthermore, the expanding network of biopharmaceuticals and biotech companies will propel segmental expansion. FUJIFILM Diosynth Biotechnologies, for example, celebrated the launch of its USD 2 billion large-scale cell culture manufacturing facility in November 2023. When completed, the new building will house state-of-the-art biopharmaceutical manufacturing technology and be the largest CDMO in North America. The new building will serve as a key component of FUJIFILM Diosynth Biotechnologies' global network for the production of biopharmaceuticals for major US and European customers.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Equipment Type |
|
|
End User |
|
|
Application |
|
North American Market Forecast
The automated cell culture market in North America is projected to be the largest with a revenue of USD 17.05 billion by the end of 2036 growing at a CAGR of 8.51% over the forecast period. The need for customized medication, the amount of research and development being done on cancer, and the existence of major rivals in the industry are all factors contributing to the growth of the automated cell culture market. An estimated 1.9 million new instances of cancer will be identified in the US in 2021, and 608,570 people will die from cancer. The market is growing as a result of developing biotechnology sectors, better cell culture technology systems, and an increased need for cell culture technology in the production of vaccines. The growing cost of healthcare is driving up demand in the market in the region. Medical research is supported by the government since healthcare is one of the main goals in the United States. Growing government funding for cell-based research is one of the main factors propelling the market's growth.
European Market Statistics
The Europe automated cell culture market is estimated to be the second-largest by developing at a CAGR of 8.92% in the given time frame. The Europe market is expected to be worth USD 10.48 billion by the end of 2036, up from USD 3.48 billion in 2023. The European market for automated cell culture is growing rapidly due to increased government support from important countries such as Russia, Germany, the United Kingdom, and Spain. Research activity in the region is also stimulated by rising R&D spending in the main European countries. For instance, the UK government announced in March 2020 the highest-ever research and development budget of USD 50.04 billion. The increasing demand for customized treatments, coupled with population aging and the advancement of new production techniques, is one of the primary factors propelling the pharmaceutical industry's growth in Europe. These factors also tend to increase the region's need for automated cell culture.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?